DCL-504

DCL-504 is an investigational bowel preparation agent being developed by Dark Canyon Laboratories specifically for the "difficult-to-prep" patient population. This group typically includes individuals who have a history of inadequate bowel cleansing, chronic constipation, or comorbidities such as diabetes or opioid use that impair gastrointestinal motility. DCL-504 is part of a specialized pipeline of gastrointestinal products designed to improve the efficacy and patient tolerability of colonoscopy preparation. The drug aims to achieve high-quality colonic mucosal visualization, which is essential for the detection and removal of precancerous polyps, by providing a more effective cleansing profile than standard routine preparations in challenging clinical scenarios.